Philips MultiTransmit adjusts radiofrequency to patient anatomy
Image quality derived from echo liver imaging at 3T (A, left) improves (A, right) when applying Philips MultiTransmit technology, which eliminatesdielectric shading, an artifact commonly found at this field strength.
Image quality derived from echo liver imaging at 3T (A) improves when applying Philips MultiTransmit technology, which eliminates dielectric shading, an artifact commonly found at this field strength. Unveiled at RSNA 2008, MultiTransmit technology automatically adjusts multiple radiofrequency signals to accommodate the anatomy of specific patients, thereby improving image uniformity and increasing overall image consistency, according to the company. The technology, which is unique to the company’s Achieva 3.0T TX, is particularly helpful in patients with liver cirrhosis and ascites (B). These ascites can be challenging to image due to shielding effects of fluids (B, inset). MultiTransmit solves the problem, decreasing B1 inhomogeneity and, thereby, improving lesion visualization. The first installations of the Achieva 3.0T TX with MultiTransmit began operating earlier this year at Tokai University in Tokyo, Bonn University in Germany, and Fletcher Allen Health Care in Burlington, VT. Users are focusing on breast, spine, and abdominal imaging. (Provided by University of Bonn)
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
